Clinical Trials Directory

Trials / Completed

CompletedNCT01926704

MTF Image Modifications

A Pilotstudy Investigating the Impact of Image Modifications on Subjective Image Quality

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

Human visual acuity and contrast sensitivity are highly dependent on various different parameters. Each should be optimized for perfect visual performance. However, in real life our eyes lack such parameters, which might lead to unsatisfying results even after spectacle correction or contact lenses. A promising approach would be to design intra ocular lenses (IOL), which are implanted into the eye for example in the course of cataract extraction and are able to compensate for the human eyes' aberrations. For example cutoff frequency, edge-sharpness or specific contrast for selected structure sizes would need to be considered. Since, an aberration free optical system is almost impossible and since the impact of each single parameter is not yet known, IOL design parameters would have to be chosen very carefully. Furthermore, image quality of IOLs still is tested ex vivo by ray tracing for example, but this does not guarantee perfect function after implantation, as our visual system has complex image precessing units form the retina to the brain. The present study picks one of these parameters and seeks to assess its impact on visual quality in-vivo. By subjectively grading different images with objective changes to image quality by variations of the modulation transfer function (MTF), the potential influence and thus on our subjective visual impression shall be assessed.

Conditions

Timeline

Start date
2013-10-01
Primary completion
2013-10-01
First posted
2013-08-21
Last updated
2014-02-19

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT01926704. Inclusion in this directory is not an endorsement.

MTF Image Modifications (NCT01926704) · Clinical Trials Directory